Cholinergic Neurotransmission, Cholinergic Drugs, Adrenergic Drugs Flashcards

(175 cards)

1
Q

MOA of skeletal muscle contraction

A

ACh binds to NICOTINIC receptors

ACh is degraded fast => suitable for NMJ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of fight or flight response

A

HR and force increases

Vascular SM contracts => increase in BP

Visceral SM relaxes

Glandular secretions reduce

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA of parasympathetic/rest & digest response

A

HR and force decreases

Visceral SM contracts

Glandular secretions increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which division of ANS has longer preganglionic axons

A

Parasympathetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Physiological effects caused by symapthetic vs PS ANS

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

8 steps in neurotransmission

A
  1. Neuron takes up precursor
  2. Synthesis of transmitter
  3. Transmitter stored in vesicles
  4. Depolarisation by AP
  5. Ca2+ influx
  6. Transmitter released by exocytosis (Ca2+ mediated)
  7. Binds to postsynaptic receptors, although not always postsynaptic
  8. Transmitter action terminated by enzymatic metabolism/reuptake
  9. Reuptake of choline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is choline taken up

A

Choline is taken into the cholinergic neuron via carrier-mediated transport

The rate limiting step for ACh production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the rate limiting step for ACh production

A

Choline being taken up by cholinergic neuron via carrier-mediated transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is ACh synthesised

A

Choline is acetylated using Acetyl CoA as a source of acetyl groups

This is catalysed by choline acetyltransferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is ACh packaged into vesicles

A

Actively packaged into vesicles by an amine transporter

Conc of ACh is very high in vesicles - 100mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Conc of ACh in vesicles

A

100 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Depolarisation of cholinergic neuron

A

nerve terminal depolarises and VG Ca2+ channels open

Ca2+ enters the nerve terminal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is ACh released by exocytosis

A

Due to Ca2+ entry, synaptobrevin on the VESICLES forms a complex with syntaxin on the inner surface of the plasma membrane thereby causing membrane fusion and exocytosis

ACh is released from nerve terminal into the synapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are syntaxin and synaptobrevin a target of

A

BOTOX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name the 2 types of ACh receptors

A

Nicotinic

Muscarinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

At what receptor is ACh more potent

A

Muscarinic receptors

i.e. larger doses are required to activate nicotinic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the subtypes of nicotinic receptors

A

Muscle - skeletal

Ganglion - ANS

CNS - brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

5 subtypes of muscarinic receptors

A

M1 - acid (gastric parietal cells)

M2 - heart

M3 - glandular/SM

M4

M5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

M1

A

Acid - gastric parietal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

M2

A

Heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

M3

A

Glandular/SM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How is ACh action terminated

A

By enzymatic breakdown in the synapse

This is catalysed by acetylcholinesterase

ACh is broken down into choline and acetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How is choline taken back up

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Noradrenergic neurotransmission - 8 steps

A
  1. Neuron takes up precursor
  2. Synthesis of transmitter
  3. Transmitter stored in vesicles
  4. Depolarisation by AP
  5. Ca2+ influx
  6. Transmitter released by exocytosis
  7. Binds to (postsynaptic) receptors
  8. Transmitter action is terminated by enzymatic metabolism/reuptake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What are catecholamines derived from What NTs are catecholamines
Derived from tyrosine Include NA, dopamine and adrenaline
26
What does the NA neuron take up
Tyrosine via carrier-mediated transport Tyrosine is an aromatic AA that is present in body fluids
27
how do noradrenergic neurons synthesise NA
Tyrosine is converted to NA in a number of steps catalysed by different enzymes The first step - hydroxylation of tyrosine - is the rate-limiting step
28
Rate limiting step in synthesis of noradrenaline
Hydroxylation of Tyrosine - tyrosine hydroxylase
29
Enzyme responsible for conversion of Tyrosine → DOPA
Tyrosine Hydroxylase
30
Enzyme responsible for conversion of DOPA → dopamine
DOPA decarboxylase
31
Enzyme responsible for conversion of dopamine → NA
Dopamine Beta-hydroxylase
32
Enzyme responsible for conversion of NA to adrenaline Where is it found
Phenylethanolamine N-methyltransferase (found in the medulla)
33
What sort of substance is adrenaline
Hormone
34
How is NA packaged into vesicles
By an amine transporter The conc of NA is very high in vesicles (0.3-1 mol/L) ATP is also stored in NA vesicles ratio of 4 molecules of ATP per molecule of NA
35
Consequences of depolarisation of nerve terminal
VG Ca2+ are opened Ca2+ enters the nerve terminal
36
How is NA released
Due to Ca2+ entry, synaptobrevin on vesicles forms complex with syntaxin on inner surface of plasma membrane thereby causing membrane fusion and exocytosis
37
What are the 2 types of NA receptors
Alpha-adrenoreceptors - α1 and α2 Beta-adrenoreceptors - β1 β2 β3
38
What are alpha-adrenoreceptors responsible for
SM contraction
39
β1 receptors
Increase rate and force of cardiac contraction
40
β2 adrenoreceptors
Found on visceral SM - relax it Bronchus, uterine
41
β3 receptors
Free source of energy from adipocytes
42
How is NA action terminated
UPTAKE 1 By reuptake in noradrenergic nerve terminals UPTAKE 2 Uptake into non-neuronal cells e.g. SM, cardiac muscle, endothelium
43
Which uptake is most important for termination of NA action
Uptake 1 (into NAergic nerve terminals)
44
What does cocaine do
Stops reuptake of NA by blocking Uptake 1 (also transporter protein for dopamine in our brains)
45
How is NA recycled or broken down
Up to 50% of NA taken up by uptake 1 is repackaged into vesicles and recycled by NAergic neuron The rest (and that taken up by reuptake 2) is metabolised
46
How is NA metabolised in the periphery
47
Enzymes used in metabolism of NA
MAO - monoamine oxidase COMT - Catechol-O-methyl transferase ADH - Aldehyde dehydrogenase
48
Periphery metabolites in metabolism of NA
DOMA - 3,2-dihydroxymandelic acid NM - normetanephrine VMA - Vanillylmandelic acid
49
Overview of NAergic neurotransmission
1. Neuron takes up tyrosine 2. Synthesis of NA 3. NA stored in vesicles 4. Depolarisation by AP 5. Ca2+ influx 6. NA released by exocytosis 7. NA binds to postsynaptic adrenoceptors 8. NA action is terminated by reuptake 9. NA recycled or metabolised by MAO or COMT
50
Where is cholinergic NT seen
NMJ - muscle nicotinic receptors ANS/Parasympathetic - muscarinic receptors (M1, M2, M3)
51
MOA of presynaptic cholinergic drugs
* Inhibit choline uptake transporter * Inhibit ACh storage transporter * Inhibit ACh release process
52
Postsynaptic cholinergic drugs - MOA
Mimic action of ACh - cholinergic agonists Block action of ACh - cholinergic antagonists
53
MOA of synaptic drugs
Inhibit AChesterase - anticholinesterases
54
Overview of drugs affecting cholinergic transmission
55
Drugs that inhibit choline uptake transporter
Hemicholinium Triethylcholine
56
Drugs that block ACh storage transporter
Vesamicol
57
Drugs that inhibit ACh release
Botulinum toxin β-bungarotoxin
58
Anticholinesterases - short duration
Edrophonium
59
Anticholinesterases - medium duration
Neostigmine Physostigmine Pyridostigmine
60
Anti-cholinesterases - irreversible
Dyflos Parathion Ecothiopate
61
Cholinergic agonists - muscarinic
Bethanacol Pilocarpine
62
Cholinergic agonists - nicotinic
Suxamethonium
63
Cholinergic antagonists - muscarinic
Atropine Hyoscine Ipratropium Pirenzepine
64
Cholinergic antagonists - nicotinic
Tubocurarine Pancuronium Atacurium Vecuronium Trimethaphan
65
MOA hemicholinium
Competitive inhibitor of choline uptake Competes with choline for binding to choline transporter Not taken up itself
66
Triethylcholine
Competitive inhibitor of choline uptake Competes with choline for uptake via the choline transporter taken up itself acetylated (by ChAT) and stored Released as a **false transmitter**
67
MOA **ves**amicol
Inhibits the vesicular acetylcholine transporter Therefore **prevents ACh transport into vesicles**
68
MOA of botulinum toxin
A protein produced by clostridium botulinum Can cause BOTULISM (rare form of food poisoning that causes resp and musculoskeletal paralysis) Contains several peptidases that cleave the proteins involved in exocytosis of ACh
69
MOA of β-bungarotoxin
Protein in venom of certain cobras Contains a phospholipase that also prevents exocytosis of ACh
70
Blockade of choline uptake
Hemicholinium Triethylcholine
71
Blockade of vesicular ACh storage
Vesamicol
72
Blockade of vesicular ACh release
Botulinum toxin β-bungarotoxin
73
What do cholinergic presynaptically-acting drugs have in common
Neuromuscular-blocking drugs
74
Which ACh receptor is more potent
Muscarinic receptors THEREFORE blocking ACh release will affect nicotinic transmission before it affects muscarinic transmission
75
What is botulinum toxin used for
Cosmetic purposes related to skeletal muscle contraction therapeutic purposes related to excessive skeletal muscle contraction/spasm painful neck spasms (cervical dystonia, torticollis) Crossed eyes (strabismus) and uncontrolled blinking (blepharospasm) Therapeutic purposes related to excessive autonomic innervation - overactive bladder/incontinence, Excessive sweating Therapeutic purposes related to excessive neurotransmitter release in the brain (Frequent and severe migraines)
76
Normal function of cholinesterase
Catalyses hydrolysis of ACh into choline & acetic acid
77
2 types of cholinesterase
Acetylcholinesterase - synaptic AChE - located in basement membrane of synaptic cleft Butyrlcholinesterase - plasma BChE - widespread distribution including plasam (suxamethonium)
78
What happens in the presence of anti-AChE
Cholinesterase is inhibited ACh accumulates Cholinergic transmission is enhanced
79
short duration anti-AChEs
Ionic bond formed is readily reversible only effective for short durations
80
How do anticholinesterases act
By binding to cholinesterase's active site Duration of action is dependent on STRUCTURE
81
Medium duration anti-AChEs
These drugs take longer to hydrolyse than ACh - mins rather than microseconds (occupy enzymes for longer)
82
Irreversible anti-AChEs
Cause the enzyme to become phosphorylated Phosphorylated enzyme is inactive Recovery depends on synthesis of new enzyme
83
Use of edrophonium
Used to clinically diagnose Myasthenia Gravis
84
Myasthenia Gravis
* Autoimmune disease in which antibodies are generated against the muscle-type nicotinic ACh receptors * Leads to destruction and loss of nicotinic receptors from the NMJ * Failure of neuromuscular transmission causing muscle weakness * Muscle weakness improves with administration of anti-AChE * Due to accumulation of ACh in NMJ synapse and enhanced NMJ neurotransmission
85
What sort of drugs are neostigmine and pyridostigmine What are they used to treat
Medium duration anticholinesterases Used to treat myasthenia gravis
86
What sort of drug is physostigmine What is it used to treat
Medium duration anticholinesterases Used to treat glaucoma
87
Glaucoma
Intraocular pressure rises due to accumulation of aqueous humour Due to iris folding over drainage pathway when the pupil is dilated - damages optic nerve
88
How do anticholinesterases treat glaucoma
Enhances PS cholinergic transmission Increased activation of M3 receptors and contraction of constrictor pupillae muscle Iris contracts Drainage pathway is unblocked Intraocular pressure is reduced
89
Name 3 irreversible anticholineaterases
Dyflos Parathion Ecothiopate
90
Dyflos
Irreversible anticholinesterase Organophosphate Used in nerve gases and insecticides Formerly used to treat glaucoma
91
Parathion
Irreversible anticholinesterase Organophosphate Used in nerve gases and insecticides Used to treat glaucoma
92
Ecothiopate
Organophosphate Used in nerve gases and insecticides Used to treat glaucoma
93
Sarin
Contains organophosphates Acts as an irreversible cholinesterase inhibitor
94
Novichock - A234
Contains organophosphates Irreversible cholinesterase inhibitor
95
Poisoning by a nerve gas leads to
Contraction of pupils Profuse lacrimation (tears) Runny nose Profuse salivation/drooling Severe bradychardia Tightness in chest Involuntary defecation Involuntary urination Convulsions and eventual death by respiratory depression (due to CNS effects of excessive ACh)
96
Recall where cholinergic transmission is located
NMJ (via nicotinic) ANS/parasympathetic (via muscarinic) - heart, visceral SM, glands
97
Cholinergic agonists
Drugs that mimic the effects of ACh Can be muscarinic and/or nicotinic
98
What are non-selective cholinergic agonists
Activate both nicotinic and muscarinic receptors like ACh itself
99
Cholinergic antagonists
Block effects of ACh Like the agonists, they can be muscarinic and/or nicotinic
100
Synonym for muscarinic agonists
Referred to as parasymptomimetics - the effects they produce are similar to the effects of PS stimulation
101
Synonym for muscarinic antagonists
Parasymptolytics Main effects they produce are similar to the effects of PS blockade
102
Agonist effect on heart
M2 receptors Reduce rate/force of contraction
103
Agonist effect on SM
M3 receptors Visceral SM contracts Pupil, bronchi, stomach, gut, bladder, uterus contract
104
agonist effect on glands
M3 receptors Glandular secretions stimulated Tears, mucus, saliva, acid, sweat
105
Antagonist effect on the heart
M2 receptors Blocks ACh induced reduction in HR - therefore HR increases
106
Antagonist effect on SM
M3 receptors Blocks ACh induced contraction of visceral SM
107
Antagonist effect on glands
M3 receptors Blocks ACh induced stimulation of secretions
108
Bethanecol
Muscarinic agonist Not cleaved by cholinesterase Used clinically to treat bladder and gut hypotonia Beneficial effects are mediated via M3 receptors
109
Pilocarpine
Not cleaved by cholinesterase Muscarinic agonist Used to treat GLAUCOMA Beneficial effects mediated by M3 receptors
110
How does pilocarpine work
Contracts constrictor pupillae muscle Iris contracts (M3 receptors) Drainage pathway is unblocked Intraocular pressure is reduced
111
Atropine
Muscarinic antagonist Extract from deadly nightshade - Atropa belladonna Naturally occuring
112
Clinical uses for atropine
Reduces secretions in anaesthesia GI hypermotility Bradycardia Anticholinesterase poisoning
113
Side effects of atropine
Urinary retention Dry mouth Blurred vision (no constriction of pupils)
114
Hyoscine (scopolamine)
Naturally occuring Extract from thorn apple (datura stramonium)
115
Clinical uses of hyoscine (scopolamine)
Reduces secretions in anaesthesia GI hypermotility Bradycardia Anticholinesterase poisoning motion sickness
116
Side effects of hyoscine (scopolamine)
Dry mouth Urinary retention Blurred vision **Sedation - crosses BBB**
117
Ipratropium
Muscarinic antagonist Used as a bronchodilator for asthma and bronchitis
118
Pirenzepine
Selectively blocks M1 receptors (on gastric parietal cells) Used to treat peptic ulcer as it reduces acid secretion, allowing ulcer to heal
119
Where are nicotinic receptors located
Muscle type - skeletal muscle Ganglion type - postganglionic neurons in all autonomic ganglia CNS type - neurons in CNS
120
Suxamethonium
Used as a muscle relaxant - during surgery so there are no inadvertent muscle twitches NMJ blocker
121
MOA of suxamethonium
Initially stimulates muscle type nicotinic receptors and causes muscle cell depolarisation, but it then causes depolarisation block
122
2 categories of nicotinic antagonists
Neuromuscular blockers - block transmission at NMJ Ganglion-blocking drugs - block both sympathetic and PS ganglia
123
Normal MOA of nicotinic receptor following binding of ACh
124
Tubocurarine
Nicotinic antagonist Neuromuscular blockers Naturally occuring Used rarely as a muscle relaxant during anaesthesia
125
Pancuronium/Atacurium/Vecuronium
Synthetic derivatives of tubocurarine Used as muscle relaxants during anaesthesia
126
2 ways in which NM blocking drugs can act
PRESYNAPTICALLY Block choline uptake Block ACh storage in vesicles Block ACh release POSTSYNAPTICALLY Block nicotinic ACh receptors non-depolarising drugs - nicotinic antagonists Depolarising blocking drugs - some nicotinic **agonists**
127
Trimetaphan
Nicotinic antagonist Ganglion blocker Used rarely to lower BP in surgery
128
S and PS effects
Mostly opposing EXCEPT BVs only have S innervation - contract vascular SM
129
Effects of ganglion blocker drugs
* Marked fall in BP - due to sympathetic ganglion block with consequent arteriolar vasodilation * Postural hypotension - reflex vasoconstriction blocked * Post-exercise hypotension - vasoconstriction in non-exercising area blocked
130
Effect of sympathetic stimulation on the body
131
9 steps in NAergic neurotransmission
1. Neuron takes up tyrosine (2 transporters) 2. Synthesis of NA 3. NA stored in vesicles 4. Depolarisation by AP 5. Ca2+ influx 6. NA released by exocytosis 7. NA binds to postsynaptic adrenoceptors 8. NA action is terminated by reuptake 9. NA recycled or metabolised by MAO or COMT \*\*\*\* no enzyme to break down NA in synapse - unique to ACh
132
MOAs of presynaptic NAergic drugs
* Inhibit NA synthesis * Reduce NA availability * Inhibit NA storage * Block NA release * Evoke NA release * Inhibit NA uptake * (Inhibit NA metabolism)
133
MOAs of postsynaptic NAergic drugs
Mimic actions of ACh - NAergic agonists Block action of ACh - NAergic antagonists
134
Drugs that inhibit NA synthesis
α-methyl-para-tyrosine Carbidopa
135
Drugs that reduce NA availability
Methyldopa
136
Drugs that block NA vesicular storage
Reserpine
137
Drugs that block NA release
Guanethedine
138
Drugs that evoke NA release
Ephedrine Amphetamine Tyramine
139
Drugs that inhibit NA uptake
Desipramine Imipramine Cocaine
140
Drugs that inhibit NA metabolism
Moclobemide Selegiline
141
Non-specific adrenergic agonists
NA, adrenaline
142
α-adrenoreceptor agonists
Clonidine
143
β-adrenoceptor agonists
Dobutamine Salbutomol Salmeterol Terbutaline Clenbuterol
144
α-adrenoceptor antagonists
Prazosin Doxazocin Terazosin
145
β-adrenoceptor antagonists
Propranalol Alprenalol Oxprenalol Atenolol
146
α-methyltyrosine
Inhibits tyrosine hydroxylase Used to treat pheochromocytoma
147
Phaeochromocytoma
Tumour of catecholamine-producing cells of adrenal medulla Because of the cancerous growth of these cells, excessive amounts of adrenaline & NA are released Inhibition of tyrosine hydroxylase prevents the synthesis of NA and adrenaline (α-methyltyrosine does this)
148
Carbidopa
Inhibits DOPA decarboxylase Does not cross BBB and thus can be used to prevent the decarboxylation of DOPA in periphery only
149
Treatment for Parkinson's
First line of treatment = dopamine precursor L-DOPA This is converted to dopamine in the brain Carbidopa prevents excessive catecholamine production in the periphery and thus prevents the peripheral side effects of L-DOPA treatment
150
Methyldopa
REDUCES NA AVAILABILITY Methyldopa is taken up by noradrenergic neurons Then converted to a false transmitter = α-methylnoradrenaline α-methylnoradrenaline is not very effective at adrenergic receptors Thus it cannot effectively cause sympathetically-mediated cardiac contraction Used to treat hypertension in pregnancy
151
Reserpine
Inhibits the vesicular NA transporter and thus blocks NA transport into vesicles NA then accumulates in cytoplasm where it is metabolised Thus, sympathetic neurotransmission is blocked and sympathetically-mediated cardiac contraction and vasoconstriction are reduced Used to be used to treat hypertension Serious side effect of depression - due to similar effect in noradrenergic and serotonergic neurons in CNS
152
Guanethidine
Inhibits release of NA from sympathetic nerve terminals MOA is unclear Impairs AP conduction Displaces NA from vesicles Can cause structural damage to NAergic neuron Used to be used for hypertension Severe side effects: postural hypotension, diarrhoea, nasal congestion
153
MOA of ephedrine (sudafed), amphetamine, tyramine (dietary amine)
These drugs evoke the release of NA from sympathetic nerve terminals and are thus called **Indirectly-acting sympathomimetic amines** MOA: Taken up by Uptake 1 Then enter vesicles in exchange for NA which accumulates in cytoplasm Some NA is then metabolised but the rest escapes in exchange for drug
154
Ephedrine/pseudoephedrine
Indirectly-acting sympathomimetic amine Used as a nasal decongestant (glandular secretions reduce in fight or flight)
155
Amphetamine
Indirectly acting sympathomimetic amine (stim. of NA release) Psychoactive stimulant (stimulates brain) Drug of abuse - speed Used to treat ADHD and narcolepsy Side effects: increased HR and BP, constipation
156
Tyramine
Indirectly acting sympathomimetic amine (stim. of NA release) Diet derived - fermented meats, ripe cheese, marmit, bovril Ordinarily metabolised by enzymes (monoamine oxidases) in gut so does not reach circulation but serious drug interaction risk (CHEESE RXN) with such foods and MAO inhibitors (tyramine) enters bloodstream EFFECTS: potentially fatal hypertensive crisis, severe throbbing headaches, intracranial haemorrhage
157
Drugs that block NA reuptake MOA
Desipramine, imipramine (tricyclic antidepressants block re-uptake of serotonin), cocaine (also blocks re-uptake of dopamine) Block neuronal reuptake by Uptake 1 thereby enhancing sympathetic nerve activity & levels of circulating NA
158
Moclobemide and selegiline
inhibit monoamine oxidase MOCLOBEMIDE - antidepressant SELEGILINE - Parkinsons - inhibits metabolism of dopamine
159
Receptor selectivity of noradrenaline and adrenaline
They show little receptor selectivity
160
α1 1. Location 2. Physiological effect
1. Vascular SM & liver 2. VasoC & glycogenolysis
161
α2 Location Physiological effect
1. Vascular SM & glands 2. VasoC & decreased glandular secretion
162
β1 1. Location 2. Physiological effect
1. Heart 2. Increased cardiac rate and force
163
β2 1. Location 2. Physiological effect
1. Bronchial SM & visceral SM, skeletal muscle, liver 2. Relaxation/dilation, relaxation, contraction/tremor, glycogenolysis
164
β3 1. Location 2. Physiological effect
1. Adipose tissue 2. Lypolysis
165
Main effects of sympathetic stimulation
Sympathetic activity exerts a powerful stimulant effect on heart - β1 adrenoceptors Overall effect of sympathetic activity is vasoC - α1 and α2 adrenoceptors Sympathetic activity strongly dilates bronchial SM - β2-adrenoceptors
166
Salbutamol, salmeterol, terbutaline
These selective β2-adrenoceptors agonists are used clinically to treat asthma Like sympathetic stimulation, these dilate bronchial SM thereby widening the airways and allowing asthmatic to breathe more easily
167
Adrenaline
Used to treat cardiac arrest
168
Dobutamine
Selective β1-adrenoceptor agonist that is used to treat cardiogenic shock - state of shock induced because the heart is unable to adequately perfuse tissues
169
Anaphylactic shock
Sudden, severe allergic rxn characterised by breathing difficulties and a sharp drop in BP
170
First line of treatment for anaphylactic shock
Adrenaline relieves breathing difficulties // bronchodilation via β2 adrenoceptors Raises BP // increased cardiac output via β1 adrenoceptors, vasoC via α 1 & 2 adrenoceptors
171
Salbutamol
Selective β2 adrenoceptor agonist treats premature labour Like sympathetic activity, it strongly dilates uterine SM by activation of β2 adrenoceptors
172
SNS and energy metabolism
Sympathetic activity encourages the conversion of energy stores (fat and glycogen) to freely available Fuels (free fatty acids and glucose) GLYCOGEN → glucose // β1 adrenoceptors in liver and muscle FAT → free FAs // β3 adrenoceptors in adipose tissue \* selective β3 adrenoceptor agonists are being developed to treat obesity (not yet approved)
173
Clenbuterol
β2 agonist - performance enhancing drug Like sympathetic activity, causes tremor in skeletal muscle thereby increasing muscle strength
174
Prazosin, doxazosin, terazosin
Selective α1 adrenoceptor antagonists used to treat hypertension Side effects include postural hypotension
175
Propranolol, alprenolol, oxprenolol, atenolol
Non-selective β-adrenoceptor antagonists (Beta blockers) used to treat hypertension, cardiac dysrhythmias and angina pectoris SIDE EFFECTS: bronchoconstriction (hence contraindicated in asthmatics) bradychardia cold extremities - blood won't perfuse to fingers and toes cardiac failure